BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:59 PM
Jul 02, 2008
 |  BC Extra  |  Company News

Bayer acquires Maxygen's hemophilia program

Bayer (Xetra:BAY) acquired all assets and IP related to Maxygen's hemophilia program. The deal includes MAXY-VII, a recombinant factor VIIa protein that is expected to enter Phase...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >